Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 250.18 million compared to CNY 248.85 million a year ago. Revenue was CNY 250.18 million compared to CNY 248.85 million a year ago.

Net income was CNY 55.07 million compared to CNY 51.82 million a year ago. Basic earnings per share from continuing operations was CNY 0.1094 compared to CNY 0.103 a year ago. Diluted earnings per share from continuing operations was CNY 0.1094 compared to CNY 0.103 a year ago.